# Henlez

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/henlez-aps

- Industry: Biotechnology
- Headquarters: Copenhagen, Denmark
- Website: www.henlez.com
- Total disclosed funding: $1M
- Latest round: Seed (Oct 24, 2022)
- Investors on record: 2

## About

Based in Denmark, and founded in 2019, Henlez ApS operates as a biotechnology company. The company was founded by its CEO Jeppe Mouritsen, and Gregor Jemec. In October 2022, Henlez raised EUR 1 million in seed funding from Karolinska Development and Eir Ventures.

Henlez develops and offers topical HEN-001, which is a precision enzyme-based treatment that utilizes enzymes to control skin problems including hidradenitis suppurativa.

The company plans to use the funds raised in October 2022 to accelerate the development of the topical HEN-001 formulation in preparation for an upcoming clinical review of the product and to broaden its patent portfolio.

## Funding rounds

- Seed, Oct 24, 2022, $1M — Karolinska Development, Eir Ventures

## Investors

- Karolinska Development — Seed
- Eir Ventures (https://capitalatlas.ai/funds/eir-ventures) — Seed